Results 141 to 150 of about 35,299 (221)

Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece. [PDF]

Front Public Health, 2023
Gourzoulidis G, Barmpouni M, Kossyvaki V, Vietri J, Tzanetakos C.   +4 more
europepmc   +1 more source

Peer Review #2 of "Temporal changes in nasopharyngeal carriage of Streptococcus pneumoniae serotype 1 genotypes in healthy Gambians before and after the 7-valent pneumococcal conjugate vaccine (v0.1)"

, 2015
Chinelo Ebruke, Anna Roca, Uzochukwu Egere, Ousainou Darboe, Philip C. Hill, Brian Greenwood, Brendan W. Wren, Richard A. Adegbola, Martín Antonio   +8 more
openalex   +1 more source

Activation of Cell‐Mediated Immunity Following Immunization with Pneumococcal Conjugate or Polysaccharide Vaccine^* [PDF]

, 2001
Tomi Wuorimaa, Helena Käyhty, Juhani Eskola, Aini Bloigu, Odile Leroy, Heljä‐Marja Surcel   +5 more
openalex   +1 more source

Upsurge of Conjugate Vaccine Serotype 4 Invasive Pneumococcal Disease Clusters Among Adults Experiencing Homelessness in California, Colorado, and New Mexico [PDF]

, 2020
Bernard Beall, Hollis Walker, Theresa Tran, Zhongya Li, Jasmine Varghese, Lesley McGee, Yuan Li, Benjamin J. Metcalf, Ryan Gierke, Emily Mosites, Sopio Chochua, Tamara Pilishvili   +11 more
openalex   +1 more source

Cost-effectiveness analysis of routine pediatric vaccination of 15-valent pneumococcal conjugate vaccine in South Korea. [PDF]

Hum Vaccin Immunother
Choe YJ, Jeon Y, Park J, Kim H, Yang G, Mohanty S, Floros L, Huang M, Chhabra N, Kumari S, Singh J, Sukarom I.   +11 more
europepmc   +1 more source

Impact of vaccination with seven-valent pneumococcal conjugate vaccine on virologic and immunologic outcomes among HIV-infected adult patients in the era of highly active antiretroviral therapy

, 2012
Ching-Lan Lu, Sui‐Yuan Chang, Hsin‐Yun Sun, Wen‐Chun Liu, Yu-Tzu Tseng, Chia-Ying Hsieh, Cheng-Hsin Wu, Chien‐Ching Hung, Shan‐Chwen Chang   +8 more
openalex   +2 more sources

Vaccination with conjugate vaccines against pneumococcal disease: What really matters

, 2020
José Cássio de Moraes, Xavier M. Pérez Porcuna, J. Nieto-Guevara, A. Eisman, Brenda Torres, J.L. Gonzalez Redondo, Xavier Sáez‐Llorens   +6 more
openalex   +1 more source

A global genomic perspective on the multidrug-resistant Streptococcus pneumoniae 15A-CC63 sub-lineage following pneumococcal conjugate vaccine introduction

, 2023
Paulina A. Hawkins, Sopio Chochua, Stephanie W. Lo, Sophie Belman, Martín Antonio, Brenda Kwambana-Adams, Anne von Gottberg, Mignon du Plessis, Jennifer Cornick, Bernard Beall, Robert F. Breiman, Stephen D. Bentley, Lesley McGee   +12 more
openalex   +1 more source

Effect of Age and Vaccination With a Pneumococcal Conjugate Vaccine on the Density of Pneumococcal Nasopharyngeal Carriage [PDF]

, 2012
Anna Roca, Christian Bottomley, Philip C. Hill, Abdoulie Bojang, Uzochukwu Egere, Martín Antonio, Ousainou Darboe, Brian Greenwood, Richard A. Adegbola   +8 more
openalex   +1 more source

Cost-effectiveness of a 13-valent pneumococcal conjugate vaccine compared with currently available pneumococcal conjugate vaccines in Indian children. [PDF]

IJID Reg
Taur SR, Rampal R, Sathyanarayanan S, Nahdi FB, Wannaadisai W, Fletcher MA, Huang L.   +6 more
europepmc   +1 more source